Home › Cancer (all types) › California › Mountain View
Cancer (all types) clinical trials in Mountain View, CA
40 studies for Cancer (all types) are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Stanford University School of Medicine, Stanford · 5 mi away
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- Stanford University, Palo Alto · 5 mi away
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecruitingPhase 3
- Quetzal Site 5, Stanford · 5 mi away
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi away
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Sutter Palo Alto Medical Foundation: Palo Alto, Palo Alto · 5 mi away
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RecruitingPhase 2/3
- Stanford Cancer Center, Stanford · 5 mi away
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- Stanford Cancer Institute, Stanford · 5 mi away
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RecruitingPhase 1
- Investigational Site Number: 403, Palo Alto · 5 mi away
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecruitingPhase 3
- Research Site, Palo Alto · 5 mi away
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RecruitingObservational study
- Stanford, Palo Alto · 5 mi away
Prostate Active Surveillance Study
RecruitingObservational study
- Stanford University, Stanford · 5 mi away
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
- Stanford University, Palo Alto · 5 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi away
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi away
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 1
- Stanford Cancer Center, Palo Alto · 5 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi away
- and 1 more
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RecruitingPhase 2
- 150, Palo Alto · 5 mi away
Evaluation of Grief Therapy Approaches for Bereaved Parents
Recruiting
- Stanford University (Data Collection Only), Stanford · 5 mi away
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RecruitingPhase 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi away
Childhood Cancer Survivor Study
RecruitingObservational studyHealthy volunteers welcome
- Stanford University School of Medicine, Stanford · 5 mi away
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Recruiting
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto · 5 mi away
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- Stanford University, Stanford · 5 mi away
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RecruitingPhase 1/2
- Stanford Women's Cancer Center, Palo Alto · 5 mi away
Galleri® in the Medicare Population.
RecruitingHealthy volunteers welcome
- Sutter Valley Hospitals PAMF Sutter, Palo Alto · 5 mi away
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
RecruitingPhase 1
- GSK Investigational Site, Stanford · 5 mi away
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RecruitingPhase 1/2
- Lucille Packard Children's Hospital Stanford, Palo Alto · 5 mi away
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RecruitingPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi away
Impact of the Coronavirus (COVID-19) on Patients With Cancer
RecruitingObservational study
- Stanford University School of Medicine, Stanford · 5 mi away
Suprachoroidal Administration in Subjects With Metastases to the Choroid
RecruitingPhase 2
- Byers Eye Institute at Stanford University, Palo Alto · 5 mi away
Engagement of Veterans With Lung Cancer
Recruiting
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi away
Adolescents and Young Adults With Cancer: Their Preferred Involvement in Decision Making
RecruitingHealthy volunteers welcome
- Stanford University, Palo Alto · 5 mi away
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
RecruitingObservational studyHealthy volunteers welcome
- Stanford University School of Medicine, Stanford · 5 mi away
Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer
Recruiting
- Stanford University, Palo Alto · 5 mi away
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RecruitingPhase 1
- Stanford Cancer Institute, Palo Alto · 5 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Stanford · 5 mi away
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
RecruitingObservational study
- Stanford Cancer Center, Palo Alto · 5 mi away
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
RecruitingObservational studyHealthy volunteers welcome
- Exai Bio Inc., Palo Alto · 5 mi away
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recruiting
- Stanford Cancer Institute, Palo Alto · 5 mi away
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RecruitingPhase 1/2
- Stanford University Cancer Institute, Stanford · 5 mi away
xPedite: A Study to Expedite DIPG and DMG Research
RecruitingObservational study
- xCures, Inc., Los Altos · 2 mi away
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX121 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Durham, NC58 studies
- Washington, DC58 studies
- Chicago, IL51 studies
- Seattle, WA49 studies
- Atlanta, GA49 studies
- Arlington, VA48 studies
Other studies in Mountain View
- Breast Cancer25 studies
- Metastatic Cancer25 studies
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Lung Cancer17 studies
- Heart Failure15 studies
- Prostate Cancer15 studies
- Autism13 studies
- Acute Lymphoblastic Leukemia13 studies
- Colorectal Cancer13 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.